• P12 Are Gains in Health Utility Associated with Gains in Work Productivity and Role Functioning in Chronic Diseases? A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project

    Jan 1, 2022, 00:00

  • POSB348 Differences in the Health-Related Quality of Life of Huntington's Disease Patients By Disease Stage in the US and EU5 from the Huntington's Disease Burden of Illness Study (HDBOI)

    Jan 1, 2022, 00:00

  • POSA116 Cost-Utility of Ribociclib As the First-Line Treatment in Postmenopausal Women with Advanced/Metastatic Breast Cancer, Hormone Receptor Positive and Human Epidermal Growth Factor Receptor-2 Negative in Colombia

    Jan 1, 2022, 00:00

  • POSC177 Healthcare Utilisation and Inpatient Mortality in Patients Hospitalised with Pneumonia with and without COPD: A Retrospective Cohort Study

    Jan 1, 2022, 00:00

  • POSA313 New Compound Real Option Approach for Management of Pharmaceutical RD Projects to Target Product Quality

    Jan 1, 2022, 00:00

  • POSB188 Burden of Disease and Cost of Illness of Alzheimer’S Disease in Portugal

    Jan 1, 2022, 00:00

  • POSC23 Reductions in Migraine and Headache Days with Quarterly and Monthly Fremanezumab in Adult Patients with Migraine in a US Real-World Setting

    Jan 1, 2022, 00:00

  • P51 Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Clinical Trial Data in Health Technology Assessment

    Jan 1, 2022, 00:00

  • POSA372 The Phollow Cohort: Quality of Life of Patients Using Antidiabetic or Oral Anticoagulants Agents in Portugal

    Jan 1, 2022, 00:00

  • POSB370 Strategies to Include Underrepresented Patient Populations in Patient-Centered Research

    Jan 1, 2022, 00:00

  • POSA50 Cost-Effectiveness Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Adolescent and Children Patients in Italy

    Jan 1, 2022, 00:00

  • POSC351 Outcome Goals for Older People Living with Frailty and Acute Care Needs: An Interview Study

    Jan 1, 2022, 00:00

  • POSC34 Comparative Efficacy and Safety of Isatuximab Plus Pomalidomide and Dexamethasone Versus Daratumumab Plus Pomalidomide and Dexamethasone in Patients with Multiple Myeloma Using a Matching-Adjusted Indirect Comparison

    Jan 1, 2022, 00:00

  • POSC399 Treatment Effect and Costs of the Complete Therapeutic Pathway in Patients with First-Line Castration-Resistant Prostate Cancer with Either First-Line Docetaxel or Abiraterone Acetate Plus Prednisone

    Jan 1, 2022, 00:00

  • POSB395 Annual Health Insurance Treatment Cost of Seropositive Rheumatoid Arthritis Based on Routinely Collected Financing Data

    Jan 1, 2022, 00:00

  • POSA208 Recognising Value of Multi-Indication Therapies: Can Pricing by Indication Benefit Payers As Well As Patients? Results of a Modelling Exercise

    Jan 1, 2022, 00:00

  • POSC154 Cost-Effectiveness of Binocular Treatment for Amblyopia: A Markov Model Framework

    Jan 1, 2022, 00:00

  • POSB355 Health-Related Quality of Life in Friedreich Ataxia: A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSA319 Development of a Diminishing Marginal Disutility Model for Intravenous Iron Infusions Based on Data from a Time Trade-Off Study in China

    Jan 1, 2022, 00:00

  • POSA158 Actualization of the Budget Impact Scale for HTA Guideline in Ukraine

    Jan 1, 2022, 00:00

  • POSB179 Epidemiological Disease Burden of Heart Failure, Unspecified Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSC230 Factors Impacting on Automated Drug Dispensing Systems Intention to Use, in the Clinical Practice

    Jan 1, 2022, 00:00

  • POSB203 Accessibility to Healthcare Services and Interventions Among Patients with Musculoskeletal Health Problems: Results from an Online Cross-Sectional Survey

    Jan 1, 2022, 00:00

  • POSC142 Cost-Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Patients in Indian Healthcare Setting

    Jan 1, 2022, 00:00

  • POSA357 Social Media Listening for Melanoma Care Across European Markets

    Jan 1, 2022, 00:00

  • POSC426 Evaluating the Impact of Strong Covariate Imbalance on Population Adjusted Indirect Treatment Comparisons: A Simulation Study

    Jan 1, 2022, 00:00

  • Reviewer Acknowledgment

    Jan 1, 2022, 00:00

  • POSA187 Epidemiological Disease Burden of Malignant Neoplasm of Larynx Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSA331 Patient Preferences for Diabetes Management in Spain - A Discrete Choice Experiment

    Jan 1, 2022, 00:00

  • POSC210 Real- World Effectiveness and Safety of Rivaroxaban in Patients with NON-Valvular Atrial Fibrillation (NVAF) and Venous Thromboembolism (VTE) in Saudi Arabia

    Jan 1, 2022, 00:00

  • POSA44 The Societal Impact of Multiple Sclerosis in Fran Results from the Petals Study

    Jan 1, 2022, 00:00

  • POSA52 A Year-on-Year Comparison Overall German Healthcare Resource Utilization in COVID Versus Non-COVID Times: A German Claims Data Analysis

    Jan 1, 2022, 00:00

  • POSC56 Healthcare Resource Use (HCRU), Cost Inputs, and Cost-Effectiveness Analysis (CEA) for Patients with Muscle Invasive Urothelial Carcinoma (MIUC) Treated with Radical Resection (RR): A Systematic Literature Review (SLR)

    Jan 1, 2022, 00:00

  • POSA198 Clinical and Economic Burden Attributable to Serotypes Included in Current and Future Pneumococcal Conjugate Vaccines in Argentinean Children Under Five Years of Age

    Jan 1, 2022, 00:00

  • POSA83 Economic Assessment of Switching Patients with Severe Hemophilia A from On-Demand Treatment to Intermediate Prophylaxis in Thailand

    Jan 1, 2022, 00:00

  • POSA340 Investigation of the Effect of Schroth Therapy and Brace Therapy on Quality of Life in Children with Idiopathic Scoliosis

    Jan 1, 2022, 00:00

  • Award Winners

    Jan 1, 2022, 00:00

  • POSA394 Mortality Curves Analysis of COVID-19 Hospitalizations in Oncologic Patients of a Private Health Care Plan in Brazil

    Jan 1, 2022, 00:00

  • POSC192 Assessment of Consumption of Inhalation Drugs for the Treatment of Bronchial Asthma in Ukraine Compared to Estonia

    Jan 1, 2022, 00:00

  • POSC285 A Comparative Analysis of Priorities and Methods of Health Technology Assessment (HTA) of Drugs in Selected Countries

    Jan 1, 2022, 00:00

  • POSC3 Real-World Treatment of Patients with TRK Fusion Cancer in Community Oncology Practice

    Jan 1, 2022, 00:00

  • POSB221 Assessing the Association between Pharmaceutical Pricing and Drug Shortages in Saudi Arabia

    Jan 1, 2022, 00:00

  • POSC235 Heart Failure Mortality in a Community-Based Population Using a Novel Algorithm for Extraction of Ejection Fraction

    Jan 1, 2022, 00:00

  • POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season

    Jan 1, 2022, 00:00

  • POSA338 Assessment of the Functional Status of Knee Osteoarthritis Patients in a Rehabilitation Institute

    Jan 1, 2022, 00:00

  • POSB239 Modelling the Impact of Screening on Future Fracture Burden Amongst Post-Menopausal Women with One Prior Osteoporotic Fracture in Greece

    Jan 1, 2022, 00:00

  • POSA56 A Cost-Effectiveness Analysis of Polatuzumab in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Portugal

    Jan 1, 2022, 00:00

  • POSC354 Treatment of Iron Deficiency without Anemia with Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease: Prospective Evaluation of Clinical and Patient-Reported Outcomes in Spain

    Jan 1, 2022, 00:00

  • POSB51 A Cost-Effectivess Analysis of Trastuzumab Emtansine Versus Trastuzumab for the Adjuvant Treatment of Patients with Residual Invasive HER2-Positive Breast Cancer in Portugal

    Jan 1, 2022, 00:00

  • POSC119 Cost-Effectiveness of Switching from the 10-Valent to the 13-Valent Pneumococcal Conjugate Vaccine in Sweden

    Jan 1, 2022, 00:00

  • POSB114 Health Care Resource Utilization and Costs Associated with Stem Cell Transplantation in Patients with Large B-Cell Lymphoma in the United States

    Jan 1, 2022, 00:00

  • POSA62 Patterns of Healthcare Expenditures Among Older United States Adults with Pain and Different Perceived Health States

    Jan 1, 2022, 00:00

  • POSC117 A Public Health and Budget Impact Analysis (BIA) of COVID-19 Vaccination in Austria

    Jan 1, 2022, 00:00

  • POSB341 Participants' Motivation for Colorectal Cancer Screening in Japan: A Secondary Qualitative Study

    Jan 1, 2022, 00:00

  • POSC363 Engaging Patients and Caregivers in Health Economic Evaluations: Generating Stakeholder Input to Inform the Conduct of an Early Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy

    Jan 1, 2022, 00:00

  • POSC390 Predictors of Insulin Pump Initiation Among People with Type 2 Diabetes from a US Claims Database Using Machine Learning

    Jan 1, 2022, 00:00

  • POSA197 Modeled Impact of Nirsevimab Against Respiratory Syncytial Virus (RSV) Among UK Infants Experiencing Their First RSV Season

    Jan 1, 2022, 00:00

  • POSC332 Stabilization of Scapulothoracal Functional Connection for Women's Junior Handball Team

    Jan 1, 2022, 00:00

  • POSA114 Stick or Twist? Cost-Effectiveness of Siponimod in the Treatment of Active Secondary Progressive Multiple Sclerosis in the UK

    Jan 1, 2022, 00:00

  • POSA369 Prescribing Practices of Antibiotics in the Acute Gastroenteritis in a Tertiary Care Hospital: A Retrospective Study

    Jan 1, 2022, 00:00

  • POSB52 Exploring the Misalignment on the Value of Further Research between Payers and Manufacturers: A Case Study on a Novel Total Artificial Heart

    Jan 1, 2022, 00:00

  • POSC326 Using Patient-Centric Qualitative Research to Inform the Design of a Discrete Choice Experiment within Relapsed/Refractory Multiple Myeloma

    Jan 1, 2022, 00:00

  • POSB233 Factors Affecting Contraceptive Use and Unmet Need for Family Planning Among HIV Positive Women in a Resource Restricted Setting

    Jan 1, 2022, 00:00

  • POSA26 Sunitinib Treatment Modification in First-line Metastatic Renal Cell Carcinoma: Analysis of a Real-World Swedish Cohort

    Jan 1, 2022, 00:00

  • POSC153 Long-Term Cost Efficiencies Linked to Automated vs. Manual Fill and Finish Process in Cell and Gene Therapy Manufacturing

    Jan 1, 2022, 00:00

  • POSC407 Monitoring of Reported COVID-19 Vaccination Rates in Community Oncology Settings

    Jan 1, 2022, 00:00

  • POSB263 Analysis of the Influence of Implicit Factors on the HTA Deliberative Process: Results of a Survey in 5 European Countries

    Jan 1, 2022, 00:00

  • POSC11 Systematic Literature Review and Network Meta-Analysis of Immunotherapy, Targeted Agents, or Combination Regimens in Treatment-Naive Unresectable or Metastatic Melanoma

    Jan 1, 2022, 00:00

  • POSA184 Epidemiological Disease Burden of Non-Insulin-Dependent Diabetes Mellitus with Coma Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSC302 Discrete Event Simulation in Severe COPD: A Feasibility Study Using DICE Methodology

    Jan 1, 2022, 00:00

  • POSC348 Impact of Socio-Economic Status on Health-Related Quality of Life in Tunisia: A Cross-Sectional Study

    Jan 1, 2022, 00:00

  • POSB389 Economic Burden of Secondary Hyperparathyroidism in Germany: A Matched Comparison Using Administrative Claims Data

    Jan 1, 2022, 00:00

  • POSC213 AIFA Assessments of Inclusion's Request in 648/96 List from January 2017 to June 2021

    Jan 1, 2022, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force [Editor's Choice]

    Jan 1, 2022, 00:00

  • POSC280 Economic Evaluation of Nivolumab Plus Ipilimumab in Advanced Renal-Cell Carcinoma in Japan

    Jan 1, 2022, 00:00

  • POSC333 Developing Strain Stabilization and Balance between Toriki Khke Competitors

    Jan 1, 2022, 00:00

  • POSB96 Economic Model for a Gene Therapy in an Ultra-Rare Disease: Expert Validation of Approach and Assumptions

    Jan 1, 2022, 00:00

  • POSB226 Variations in Inferior Vena Cava Filter Placement Among Medicare Beneficiaries with Acute Venous Thromboembolism

    Jan 1, 2022, 00:00

  • POSC424 Registry-Based Studies in Practi Enhancing Real-World Evidence Generation in Rare Disease and Personalized Medicine

    Jan 1, 2022, 00:00

  • POSB38 Developing a Cost-Effectiveness Analysis for Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in the Absence of Overall Survival Data

    Jan 1, 2022, 00:00

  • POSC328 Impact of Treatment Schedule on Adherence and Persistence in Osteoporosis Patients Receiving Long-Acting Therapeutics

    Jan 1, 2022, 00:00

  • POSA97 Assessment of the Economic IMPACT in Relation with the Use of Sugammadex in the French Hospitals Setting

    Jan 1, 2022, 00:00

  • POSA58 Cost-Effectiveness (CE) Analyses for First-Line (1L) Treatment of Advanced or Metastatic Urothelial Carcinoma (MUC): A Systematic Literature Review (SLR)

    Jan 1, 2022, 00:00

  • POSB134 Economic Impact and Public Health Benefit of Influenza Immunization by Pharmacists in France

    Jan 1, 2022, 00:00

  • POSA66 Analysis of the Economic Consequences of the Evolution of the Community-Based HIV Care Model in Mali

    Jan 1, 2022, 00:00

  • P39 Better Outcomes and Value for Money with Cost-Effectiveness Modelling of Cascade Screening Strategies for Familial Hypercholesterolaemia

    Jan 1, 2022, 00:00

  • POSC266 Is Ultra-Orphan Disease Treatment Access Equitable in the UK? Comparison between SMC and NICE HST Guidance

    Jan 1, 2022, 00:00

  • POSC322 The Impact of Treatment Coefficient Parameterization for Mixture Cure Models on Cost-Effectiveness Models

    Jan 1, 2022, 00:00

  • POSC412 Economic Burden of Diabetes in Italy from the Social Security System Perspective

    Jan 1, 2022, 00:00

  • POSC418 Long-Term Evolution of Hospital Resource Utilization and Associated Costs Using Adjustment Methods: in Patients Treated with Nivolumab for Advanced Non-Small Cell Lung Cancer

    Jan 1, 2022, 00:00

  • POSB424 Valuation of Cognitive Impairment in Schizophrenia

    Jan 1, 2022, 00:00

  • POSC396 Real-World Treatment Pattern and Direct Medical Costs of Atopic Dermatitis in China: A Retrospective Claims Database Analysis

    Jan 1, 2022, 00:00

  • POSC36 Implantable Cardiac Defibrillators in Heart Failure Patients: An Overview of Reviews and Meta-Analysis

    Jan 1, 2022, 00:00

  • POSB142 Targeted Literature Review of the Burden of Illness in Late-Stage Duchenne Muscular Dystrophy (DMD)

    Jan 1, 2022, 00:00

  • POSC260 Evaluating the Impact of Patient Reported Outcomes Data on HTA Reimbursement Decisions

    Jan 1, 2022, 00:00

  • POSA71 Cost-Effectiveness of NT-PRO-BNP in Patients with Chronic Heart Failure with or without Type 2 Diabetes Mellitus in Austria

    Jan 1, 2022, 00:00

  • POSB131 Equity and Health Inequalities: Should DCEA be Considered for Decision Making in the United Kingdom?

    Jan 1, 2022, 00:00

  • POSC346 Quality of Life of Breast Cancer Patients Treated in a University Hospital in Alexandria, Egypt

    Jan 1, 2022, 00:00

  • POSA258 Leveraging RWE and Integrating Multi-Source Data to Build the Case for Funding and Access for Rare Disease Drugs

    Jan 1, 2022, 00:00

  • POSB269 The Use of External Data to Inform Survival Extrapolation in Oncology Technology Appraisals: A Comprehensive Review

    Jan 1, 2022, 00:00

  • POSA108 A Budget Impact Analysis of Atezolizumab Monotherapy for First Line Treatment of Patients with PD-L1 High Metastatic NSCLC in Italy

    Jan 1, 2022, 00:00

  • POSC181 Epidemiological Disease Burden of Mental and Behavioural Disorders Due to Use of Opioids Based on Routinely Collected Health Insurance Claims DATA

    Jan 1, 2022, 00:00

  • POSB290 Artificial Intelligence in Medical Diagnostics: A Review of NICE MedTech Innovation Briefings

    Jan 1, 2022, 00:00

  • POSB25 Public Health Benefit of Switching to High Dose Quadrivalent Vaccine for Influenza Seasonal Vaccination in Portuguese Elderly Population.

    Jan 1, 2022, 00:00

  • POSC144 Cost Analysis for Macrovascular Events in Controlled and Suboptimal Controlled Diabetes Mellitus Type 2 Population in Colombia

    Jan 1, 2022, 00:00

  • POSA426 Assessment of the Economic Impact of Fibrodysplasia Ossificans Progressiva on Patients and their Families Using an International Burden of Illness Survey

    Jan 1, 2022, 00:00

  • POSA361 Weight Change and Diabetes Medications: Is There an Association with Adherence and Discontinuation?

    Jan 1, 2022, 00:00

  • POSC197 Gender Difference in Heart Failure (HF) after ST-Segment Elevation Myocardial Infarction (STEMI)

    Jan 1, 2022, 00:00

  • POSB311 Reviewing the Use of Matching Adjusted Indirect Comparisons in Health Technology Assessment Submissions

    Jan 1, 2022, 00:00

  • POSB237 Measures to Evaluate Quality of Care in Head and Neck Cancer: Interim Results of a Delphi Study

    Jan 1, 2022, 00:00

  • POSC324 Clinical Pharmacist Intervention to Improve the Administration of Injectable Antiviral Agents By Nurses in the Treatment of COVID-19 Infection.

    Jan 1, 2022, 00:00

  • POSC27 Comparing Length of Stay of Open, Video-Assisted Thoracoscopic, and Robot-Assisted Lobectomy in Japan

    Jan 1, 2022, 00:00

  • POSB121 Economic Evaluation of the Impact Results of Hydroxocobalamin Use in Victims of Suspected Cyanide Poisoning Caused by Smoke Inhalation

    Jan 1, 2022, 00:00

  • POSA7 Clinical and Health-Related Quality of Life (HRQOL) Outcomes from Interventional Studies in First-Line (1L) Advanced or Metastatic Urothelial Cancer (MUC): A Systematic Literature Review (SLR)

    Jan 1, 2022, 00:00

  • POSC76 Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece

    Jan 1, 2022, 00:00

  • POSB196 Epidemiology of Osteoporosis: Risk Factor Distribution, Osteoporosis Prevalence and Treatment Gap in the General Population ≥50 Years of Age in Germany

    Jan 1, 2022, 00:00

  • POSA122 Budget Impact Analysis of Introducing Ceftolozane/Tazobactam Injection for Treatment of Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections in the Ministry of Health Malaysia Facilities

    Jan 1, 2022, 00:00

  • POSC389 Characterisation of Existing Treatment Patterns in Muscle-Invasive Urothelial Carcinoma (MIUC) Across North America, Europe, and East Asia

    Jan 1, 2022, 00:00

  • POSB157 Demographics and Treatment Patterns of Onychomycosis Patients Claiming Efinaconazole: A Canadian Retrospective Claims Analysis Stratified By Diabetes Status

    Jan 1, 2022, 00:00

  • POSC196 Modelling the Public Health Impact of Alternative Vaccine Strategies Following the Discontinuation of Menitorix (HIB/MENC) in England

    Jan 1, 2022, 00:00

  • POSB2 A Targeted Review of Published Meta-Analyses for LDL-C Lowering Treatments Beyond Statins: Bempedoic Acid, Ezetimibe, and PCSK9-Inhibitors Including Inclisiran

    Jan 1, 2022, 00:00

  • POSB232 Understanding the Patient Journey By Establishing the Care Delivery Value Chain Among Patients with Rheumatoid Arthritis

    Jan 1, 2022, 00:00

  • POSA266 Capturing the Value of Potentially Curative Oncology Therapies: Lessons from the Use and Acceptance of Cure Modelling Assumptions in NICE Technology Appraisals

    Jan 1, 2022, 00:00

  • POSB24 Long-Term Survival Associated With Next-Generation Sequencing Versus Standard Diagnostic Tests To Detect Epidermal Growth Factor Receptor Exon 20 Insertion Variants In Non-Small-Cell Lung Cancer: A Decision-Analytic Model

    Jan 1, 2022, 00:00

  • POSC270 The Impact of Clinical and Economic Evidence on Reimbursement Decisions in Narcolepsy

    Jan 1, 2022, 00:00

  • POSA101 Modeling Approaches in Cost-Effectiveness Analyses of Cell Therapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    Jan 1, 2022, 00:00

  • POSA22 Do We Need to Mind the Gap: An Analysis of the Evidence Base Differences and Alignment across Regulator and HTA Agencies

    Jan 1, 2022, 00:00

  • POSC97 Breast Cancer Patient Pathway: Direct Costs for the Portuguese NHS of a Breast Cancer Patient

    Jan 1, 2022, 00:00

  • POSA115 Is There a Difference between the Willingness to Pay for Antimicrobials and Other Curative Treatments? A Cost per Cure Analysis of Curative Therapies in Spain

    Jan 1, 2022, 00:00

  • POSA335 Efficiency of a 12-Week Core Training Program to Develop the Neuromuscular Control Among Amateur Dancers

    Jan 1, 2022, 00:00

  • POSA378 Derivation of Interpretation Thresholds for the Rheumatoid Arthritis Symptoms and Impact Questionnaire (RASIQ) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-FATIGUE) Scale

    Jan 1, 2022, 00:00

  • POSA128 Cost-Effectiveness Analysis of Avelumab Plus Best Supportive Care (BSC) vs BSC Alone as a First-Line (1L) Maintenance Treatment for Patients With Locally Advanced or Metastatic Urothelial Carcinoma in Taiwan

    Jan 1, 2022, 00:00

  • POSA343 Humanistic and Economic Burden of Retinitis Pigmentosa in Japan: Findings from a Literature Review

    Jan 1, 2022, 00:00

  • POSA29 A New Patient-Focused Progression Model for Geographic Atrophy

    Jan 1, 2022, 00:00

  • POSB159 Comparing Modeled Outcomes with Published Studies in the Japanese Setting: A Validation Analysis with the Prime Type 2 Diabetes Model

    Jan 1, 2022, 00:00

  • P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study

    Jan 1, 2022, 00:00

  • POSA46 Cost Analysis of Lurasidone for the Treatment of Schizophrenia in Adults within the United Kingdom

    Jan 1, 2022, 00:00

  • POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study

    Jan 1, 2022, 00:00

  • POSB287 HBA1C Point-of-Care Testing for Diabetes Control in a Low-Income Population: A Before and After Study

    Jan 1, 2022, 00:00

  • POSC398 Burden of Illness of Urinary Tract Infections in Subjects with Bladder Dysfunction or Urinary Retention: A Danish Register Study

    Jan 1, 2022, 00:00

  • POSB77 Comparing the Total Costs of Oral Disease Modifying Therapies for Patients with Active Relapsing Multiple Sclerosis in the US

    Jan 1, 2022, 00:00

  • POSA24 Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in Previously Untreated Advanced Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

    Jan 1, 2022, 00:00

  • POSC295 Delay in Shock Wave Lithotripsy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease

    Jan 1, 2022, 00:00

  • POSC259 Comparative Efficacy and Safety of Treatments for Latent Tuberculosis in Children and Adolescents: A Network Meta-Analysis

    Jan 1, 2022, 00:00

  • POSA221 5-Years On: Reflections on the Cancer Drugs Fund

    Jan 1, 2022, 00:00

  • POSC228 Hospital Unit Costs in Jordan: An Analysis Where Competing Demands Meets with a Thrive for Better Financing of Universal Health

    Jan 1, 2022, 00:00

  • POSC17 A TARGETED LITERATURE REVIEW TO COMPARE COVID-19 SYMPTOM DIARIES AND PATIENT-REPORTED CONCEPT

    Jan 1, 2022, 00:00

  • POSA289 Hospital Budget Impact Analysis on the Use of EEG ESI for Complex, Non-Lesional Epilepsy Surgery Evaluation

    Jan 1, 2022, 00:00

  • POSC91 Economic Burden of Multiple Myeloma According to Treatment Lines in France from 2014 to 2019, the Mylord Study

    Jan 1, 2022, 00:00

  • POSB58 Digitisation of Water Treatment Systems: Impact on Cost and Processes in a Renal Care Provider Network - A Value-Based Procurement Approach

    Jan 1, 2022, 00:00

  • POSC75 Quality of Life of Caregivers of Pediatric Patients with Atopic Dermatitis: A Quantitative Assessment of Utilities from EQ-5D

    Jan 1, 2022, 00:00

  • POSB398 Kaplan-Meier Survival Curves Analysis of Hospitalized COVID-19 Beneficiaires of a Health Care Plan in Brazil

    Jan 1, 2022, 00:00

  • POSA325 A Comprehensive Overview of the First Educational Trainings According to New HTA Guideline for Medicines in Ukraine

    Jan 1, 2022, 00:00

  • POSC430 Unmet Needs for Insomnia Patients - Economic Burden in Europe

    Jan 1, 2022, 00:00

  • POSA370 Healthcare Resource Use By European Patients Enrolled in RA-be-Real: A Multinational, Prospective, Observational Study of the Effectiveness, Healthcare Resource Utilization and Costs in Patients with Rheumatoid Arthritis Receiving B ...

    Jan 1, 2022, 00:00

  • POSC158 The Burden of Spinal Muscular Atrophy Type 1 (SMA1) on Caregivers in Japan: First Results of a Global Survey

    Jan 1, 2022, 00:00

  • POSC99 Comparator Pricing Confidentiality and Transparency in HTA Decision Making: A Comparative Analysis of the Nordic Markets

    Jan 1, 2022, 00:00

  • POSA67 Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Versus Dual Therapies in Moderate-to-Very Severe COPD: United Kingdom Analysis Using the ETHOS Study

    Jan 1, 2022, 00:00

  • POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries

    Jan 1, 2022, 00:00

  • POSA404 Caregiver Trends in Absence Payments and Lost Time Due to Sick Leave, Long- and Short-Term Disability and Workers' Compensation for Employees Whose Spouses Have Back Pain in the United States

    Jan 1, 2022, 00:00

  • POSB272 Use of Real-World Evidence for Reimbursement in Brazilian Public Sector: An Analysis of Submissions in Neurology and Rheumatology

    Jan 1, 2022, 00:00

  • POSB231 How to Determine Surgical Pathway Operating Costs in Chronic Rhinosinusitis with Nasal Polyposis Patients? The Time Driven Activity-Based Costing Experiment

    Jan 1, 2022, 00:00

  • POSA155 The Epidemiology and Economic Burden of Different Phenotypes of Multiple Sclerosis (MS) in Italy: Relapsing-Remitting Multiple Sclerosis (RRMS) and Secondary Progressive Multiple Sclerosis (SPMS)

    Jan 1, 2022, 00:00

  • POSC15 Addressing Glucocorticoid-Induced Hyperglycemia in COVID -19 Patients: The Expanding Role of Steroid Stewardship

    Jan 1, 2022, 00:00

  • POSB410 Absence Time and Payments Due to Sick Leave, Long- and Short-Term Disability and Workers' Compensation for Employees with Nervous System Disorders in the United States

    Jan 1, 2022, 00:00

  • The EQ-5D-5L in Practice in Europe and Beyond: Advantages and Limitations

    Jan 1, 2022, 00:00

  • POSB141 The Health Benefits of Treatment with Fostemsavir in Highly Treatment Experienced HIV-1 Infected Individuals

    Jan 1, 2022, 00:00

  • POSA326 Cross-Border Collaboration to Support Pricing and Access for High-Cost, High-Value Therapies: A Review of Initiatives within Europe

    Jan 1, 2022, 00:00

  • POSA107 Apixaban Versus Other Anticoagulants in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: A Comparison of All-Cause and Event-Related Costs in Real-Life Setting in France

    Jan 1, 2022, 00:00

  • POSA272 Using Real World Evidence to Characterise Utility in Patients with a Rare Disease: Analysis of Pompe Registry Data

    Jan 1, 2022, 00:00

  • POSB18 A Syliterature Review of the Clinical Evidence on ND:YAG Laser Capsulotomy Incidence Post-Cataract Surgery in Eyes Implanted with the Clareon Intra-Ocular LENS (IOL) Implanted Eyes

    Jan 1, 2022, 00:00

  • Two Years of COVID-19: What Has Been the Global Impact on HRQoL and Clinical Outcomes?

    Jan 1, 2022, 00:00

  • POSC93 Economic Burden of Nonalcoholic Steatohepatitis in China

    Jan 1, 2022, 00:00

  • POSC221 Payer and Industry Views on the Legislative Proposal for Joint Work on European Health Technology Assessment Approach

    Jan 1, 2022, 00:00

  • POSA407 Perceptions of Clinicians on the Use of Real-World Evidence in Oncology: An EORTC Survey

    Jan 1, 2022, 00:00

  • POSA333 Real-World Evidence of Benign Prostatic Hyperplasia (BPH) in Germany

    Jan 1, 2022, 00:00

  • POSB187 Study of Awareness of Pharmacy Employees in Ukraine with the Problem of Antibiotics Resistance

    Jan 1, 2022, 00:00

  • POSC194 Treatment-Resistant Depression and Major Depression with Severe Suicide Risk: The Cost of Illness and Burden of Disease in Portugal

    Jan 1, 2022, 00:00

  • POSC264 Negotiation Agreements with AIFA from January 2017 to May 2021 - Focus on Orphan Drugs

    Jan 1, 2022, 00:00

  • POSA233 The Indirect Health Economic Consequences of the COVID-19 Pandemic on English Hospitals: A Scoping Review

    Jan 1, 2022, 00:00

  • POSA353 Conceptual Models of the Patient Experience of Duchenne Muscular Dystrophy Constructed from a Qualitative Interview Study with Caregivers

    Jan 1, 2022, 00:00

  • Impact of the COVID-19 Pandemic: Healthcare Utilisation and Outcomes

    Jan 1, 2022, 00:00

  • POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients

    Jan 1, 2022, 00:00

  • POSB36 Disease Burden of Chronic Myeloid Leukemia (CML) Treatment Failure in Mainland China: A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSA389 Who Can We See in RWD? Assessing Capture of Demographic Data Across Multiple Countries

    Jan 1, 2022, 00:00

  • POSB324 Correlation of Amyloid Levels and Cognitive Impairment in Patients with Alzheimer's Disease: A Systematic Literature Review.

    Jan 1, 2022, 00:00

  • POSB180 Epidemiological Disease Burden of Knee Osteoarthritis Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSB104 Cost-Minimization Analysis of Two 3rd-Generation Bovine Pericardial Aortic Valve Prosthesis for Aortic Valve Replacement in Brazil and Mexico

    Jan 1, 2022, 00:00

  • POSC211 Effects of the Policy Regulation on Generic Competition and Pharmaceutical Savings in Portugal. Do Incentives Matter?

    Jan 1, 2022, 00:00

  • POSA142 Cost Effectiveness of Treatment Optimization with Biomarkers for Immunotherapy in Solid Tumors: A Systematic Review

    Jan 1, 2022, 00:00

  • POSC248 Real-World Patient Characteristics and Treatment Patterns in Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS P.G12C Mutant Tumors in Italy

    Jan 1, 2022, 00:00

  • POSA79 Budget Impact Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece

    Jan 1, 2022, 00:00

  • POSA132 Validity of Long-Term Oncology Modeling Extrapolations: A Case Study in Recurrent or Metastatic Head and Neck Cancer

    Jan 1, 2022, 00:00

  • POSA287 Transferability of Disease-Related Costs of Chronic Immune-Mediated Diseases within Countries of the Middle East North Africa Region: The Case of Multiple Sclerosis

    Jan 1, 2022, 00:00

  • POSC383 Access to Electronic Health Records for Research Purposes - Exciting Experiences of a Multidisciplinary Research Project

    Jan 1, 2022, 00:00

  • POSB310 The Impact of Small Sample Size on Selecting Appropriate Distributions for Parametric Survival Extrapolations Models: A Methodological Commentary and Simulation Study

    Jan 1, 2022, 00:00

  • POSB315 ASM Revisited: Simplifying the Backward Shift

    Jan 1, 2022, 00:00

  • POSB123 Cost-Effectiveness of Granulocyte Colony Stimulating Factors (G-CSFS) for the Prevention of Febrile Neutropenia in Breast Cancer Patients

    Jan 1, 2022, 00:00

  • POSC6 Efficacy and Safety Results from Real-World Studies Evaluating Adjuvant Treatment after Radical Resection (RR) of Muscle Invasive Urothelial Carcinoma (MIUC): A Systematic Literature Review (SLR)

    Jan 1, 2022, 00:00

  • POSB172 A Review of the Risks of Long-Term Consequences Associated with Components of CHOP Chemotherapy Regimen

    Jan 1, 2022, 00:00

  • POSB256 Innovative Contracting Schemes for Cell and Gene Therapies in France, Germany, Italy, Spain, and UK

    Jan 1, 2022, 00:00

  • POSA37 Achievement of LDL-C Targets in Chinese Patients with Very High Risk Atherosclerotic Cardiovascular Disease Receiving Intensive Lipid Lowering Therapy

    Jan 1, 2022, 00:00

  • POSA13 Dupilumab Treatment Reduces Hospitalizations in Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of DATA from 7 Randomized, Placebo-Controlled Studies

    Jan 1, 2022, 00:00

  • POSA177 Real-World Profiling of Non-Small Cell Lung Cancer Patients in Japan

    Jan 1, 2022, 00:00

  • POSC263 A Systematic Literature Review of the Economic and Humanistic Burden of Cardiac AL Amyloidosis (AL-A)

    Jan 1, 2022, 00:00

  • POSB367 Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease Across 7 Countries in Europe Using a Discrete Choice Experiment

    Jan 1, 2022, 00:00

  • POSB213 Assessing the Changes of Hungarian Health Professional Workforce, Proportional to Population between 2003-2018

    Jan 1, 2022, 00:00

  • POSC272 How Does the Japanese CE-HTA Compare with ROW?

    Jan 1, 2022, 00:00

  • POSB408 Medication Adherence Impacts Productivity Costs, Lost Time, and Emergency Room Visits in Employees with Major Depressive Disorder

    Jan 1, 2022, 00:00

  • POSC187 Epidemiology of Lung Cancer in China: A Targeted Literature Review

    Jan 1, 2022, 00:00

  • POSA411 Real World Outcomes of First Line Pembrolizumab Monotherapy for Advanced PD-L1 Positive Non-Small Cell Lung Cancer

    Jan 1, 2022, 00:00

  • POSA229 Understanding Antibiotic Susceptibility Patterns of Bacterial Isolates: Crucial in Determining Empirical Therapy in Intensive Care Units

    Jan 1, 2022, 00:00

  • Is Social Media Information Useful to Understand Patient Experiences and the Burden of Disease?

    Jan 1, 2022, 00:00

  • POSA163 Estimating the Budget Impact of the Introduction of Filgotinib for the Treatment of Ulcerative Colitis in Spain

    Jan 1, 2022, 00:00

  • POSC338 Efficiency Test of a Core Training Program Among Primary School Students

    Jan 1, 2022, 00:00

  • Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications

    Jan 1, 2022, 00:00

  • POSA59 Using Disease Registries for Cost of Illness Studies: The European Bronchiectasis Registry Case

    Jan 1, 2022, 00:00

  • POSB78 Economic Analysis of Adherus Autospray Dural Sealant As an Adjunct to Standard Methods of Dural Repair to Provide Watertight Closure during Cranial Procedures: Postoperative Complications and Costs

    Jan 1, 2022, 00:00

  • POSC400 Epidemiology and Patients' Characteristics in Multiple Sclerosis: An Analysis from the Italian Multiple Sclerosis Registry

    Jan 1, 2022, 00:00

  • POSB299 A New Method for Adjusting Health State Utilities to Increase Their Transferability from UK to Italy

    Jan 1, 2022, 00:00

  • POSC394 Annual Health Insurance Treatment Cost of Knee Osteoarthritis Based on Routinely Collected Financing Data

    Jan 1, 2022, 00:00

  • POSA20 Project Hercules - Burden of Steroid Use in the Treatment of Duchenne Muscular Dystrophy: Findings from a Targeted Literature Review and Online Survey

    Jan 1, 2022, 00:00

  • POSB416: The Oscar Project: 'One Stop Shop for Clinical Research' on Danish Real World Data

    Jan 1, 2022, 00:00

  • POSB22 Indirect Treatment Comparisons of Empagliflozin Versus Sacubitril/Valsartan for the Treatment of Patients with Heart Failure with Reduced Ejection Fraction (HFREF)

    Jan 1, 2022, 00:00

  • POSC350 Health Utility Values in the STEP 1–4 Trials of Semaglutide 2.4 MG in Obesity

    Jan 1, 2022, 00:00

  • POSC406 Productivity Loss Associated with Premature Deaths Due to Chronic Lymphocytic Leukemia and Multiple Myeloma in Slovakia: Results from 2017 Until 2019

    Jan 1, 2022, 00:00

  • POSB80 Annual Health Insurance Treatment Cost of Non-Insulin-Dependent Diabetes with Ophthalmic Complications Based on Routinely Collected Financing Data

    Jan 1, 2022, 00:00

  • POSB376 Limited Published Quantitative Evidence on Medication Adherence of Multimorbid Elderly Women with Polypharmacotherapy: Results of a Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSA398 Real World Use of Cladribine Tablets in Portugal: Snapshot of a Cohort Database

    Jan 1, 2022, 00:00

  • POSB171 Using French Administrative Database to Identify Patients with Unresectable/Locally Advanced or Metastatic Esophageal Cancer in France

    Jan 1, 2022, 00:00

  • POSA176 Knowledge, Perception, and Attitude of Pharmacists, Physicians, and Patients Toward Generic Drugs in Yogyakarta Province, Indonesia

    Jan 1, 2022, 00:00

  • Using Real World Evidence in Simulation Models

    Jan 1, 2022, 00:00

  • POSB55 Economic Consequences of Anti-HCV Treatment of Patients Diagnosed through Screening in Italy: A Prospective Modelling Analysis

    Jan 1, 2022, 00:00

  • POSC222 Eureca - Exploring Reimbursement Models for Medication Adherence Enhancing Interventions in European Countries: A Survey Protocol

    Jan 1, 2022, 00:00

  • POSB182 Epidemiological Disease Burden of Hip Osteoarthritis Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSB20 Health Technology Assessment (HTA) of BRAF/MEK Inhibitors in Non-Resectable Metastatic BRAFV600 Melanoma Patients

    Jan 1, 2022, 00:00

  • POSB286 Assessing the Methodology and Transferability of Cardiovascular Hospitalisation Costs within the Middle East North Africa Region

    Jan 1, 2022, 00:00

  • POSA365 Does Undiagnosed Depression in Stroke Patients Affect the Total Healthcare Expenditures and Health-Related Quality of Life: An Analysis Using Medical Expenditure Panel Survey Data, 2016-2018

    Jan 1, 2022, 00:00

  • POSA399 Treatment Pattern, Mortality and Costs Among BCG-Treated Non-Muscle Invasive Bladder Cancer (NMIBC) Patients in Germany

    Jan 1, 2022, 00:00

  • POSA57 Axicabtagene Ciloleucel and Tisagenlecleucel for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain: A Cost-Effectiveness Analysis

    Jan 1, 2022, 00:00

  • POSC237 The Monitoring of Prescription Appropriateness for Achieving the Objectives of Pharmaceutical Spending and Providing Essential Levels of Assistance

    Jan 1, 2022, 00:00

  • POSB56 Cost-Effectiveness of Satralizumab Compared to Eculizumab for the Treatment Neuromyelitis Optica Spectrum Disorders (NMOSD) in Adult and Adolescent Patients Who Are Anti-Aquaporin 4 (AQP4) Seropositive in Canada

    Jan 1, 2022, 00:00

  • POSC427 Platform Trials: A Path to Efficient Decision Making and Faster Drug Approvals for Health Technology Assessment Bodies

    Jan 1, 2022, 00:00

  • POSC50 Cost-Effectiveness of Addition of Intravenous Tranexamic Acid to Management of Primary Post-Partum Haemorrhage in Indian Public Health Settings

    Jan 1, 2022, 00:00

  • POSA215 Public and Household Healthcare and Pharmaceutical Spending Analysis in Bulgaria in Four Years Period

    Jan 1, 2022, 00:00

  • POSA423 Healthcare Resource Utilization (HRU) Survey to Inform HRU Data Collection Alongside the Double-Blinded Trilynx Study Evaluating Xevinapant in Combination with Chemoradiotherapy Versus Placebo Plus Chemoradiotherapy in Patients with ...

    Jan 1, 2022, 00:00

  • POSA17 A Clinical Systematic Review of Treatment Options for Metastatic Uveal Melanoma

    Jan 1, 2022, 00:00

  • POSA118 Low-Value Care Among People Living with Dementia and Its Association with Healthcare Resource Utilization and Costs

    Jan 1, 2022, 00:00

  • POSC188 Analysis of Hospital Incidence and Direct Medical Costs of Intrahepatic Cholangiocarcinoma in Spain

    Jan 1, 2022, 00:00

  • Methods and Controversies in the Evaluation of Oncology Products

    Jan 1, 2022, 00:00

  • POSB98 Evaluating the Return on Investment of Tobacco Control Intervention in Indonesia

    Jan 1, 2022, 00:00

  • POSB64 Estimation of Health Utility Scores for People with Glycogen Storage Disease Type IA

    Jan 1, 2022, 00:00

  • POSC359 The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide Liraglutide in Type 2 Diabetes Patients (TROPHIES): Patient Reported Outcomes at 12-Months

    Jan 1, 2022, 00:00

  • POSB356 Health-Related Quality of Life across King's and Mitos Stages Among Amyotrophic Lateral Sclerosis Patients: Results from a Real-World Point-in-Time Survey

    Jan 1, 2022, 00:00

  • P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany

    Jan 1, 2022, 00:00

  • POSA391 Real-World Long-Term Overall Survival in Metastatic Cancer in Sweden

    Jan 1, 2022, 00:00

  • P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data

    Jan 1, 2022, 00:00

  • POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany

    Jan 1, 2022, 00:00

  • POSB235 Effectiveness and Cost-Effectiveness of a Collaborative Deprescribing Intervention of Proton-Pump Inhibitors on Community-Dwelling Elderly (C-SENIOR Trial): A Study Protocol

    Jan 1, 2022, 00:00

  • POSB297 Assessing the Cost and Value Drivers of Automation in Cell and Gene Therapy Manufacturing: A Decision Guide

    Jan 1, 2022, 00:00

  • POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes

    Jan 1, 2022, 00:00

  • POSB181 Epidemiological Disease Burden of Non-Insulin-Dependent Diabetes Mellitus with Other Specified Complications Based on Routinely Collected Health Insurance Claims Data

    Jan 1, 2022, 00:00

  • POSC227 What Are the Main Barriers for Achieving Low-Density Lipoprotein Cholesterol Goals in Post Myocardial Infarction Patients? Perspectives from Physicians in Six European Countries

    Jan 1, 2022, 00:00

  • POSC24 Surrogate Endpoints for Overall Survival (OS) in Advanced Melanoma: A Targeted Literature Review (TLR) of Correlation Meta-Analyses

    Jan 1, 2022, 00:00

  • POSC255 European Cross-Country Collaborations: A Focus on Joint HTA Initiatives and Their Future Implications for Orphan Drugs

    Jan 1, 2022, 00:00

  • POSB330 Patient Preferences for Robotic- and Assistance Technologies in Health Care

    Jan 1, 2022, 00:00

  • POSB17 Ozanimod for the Treatment of Biologic-Experienced Patients with Moderate-to-Severe Ulcerative Colitis: Results from a Systematic Literature Review and Network Meta-Analyses

    Jan 1, 2022, 00:00

  • POSC232 Characterization of Pediatric Patients with Atopic Dermatitis in Portugal: Results from an Online Physician Survey

    Jan 1, 2022, 00:00

  • P40 HTA Agencies Perspective on Survival Modelling in Cell or Gene Therapy Appraisals

    Jan 1, 2022, 00:00

  • POSC372 The Phollow Cohort: Real-World Therapeutic Adherence to ORAL Anticoagulants in Portugal

    Jan 1, 2022, 00:00

  • POSA293 Physician-Reported Barriers to BRCA and HRD/HRRm Testing in Oncology Care: An Interview Based Study

    Jan 1, 2022, 00:00

  • POSA110 Cost-Effectiveness Analysis of Pembrolizumab Versus Brentuximab Vedotin (BV) in Adult and Paediatric Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma in France

    Jan 1, 2022, 00:00

  • P11 Development of an EQ-5D-5L Value Set for Italy Using Videoconferencing Administered Personal Interviews: Reporting on the Feasibility of a New Mode of Administration for Valuation Studies

    Jan 1, 2022, 00:00

  • POSA351 Dyadic Evaluation of Patient and Caregiver Treatment Burden with Once Weekly Growth Hormone (GH) Injection Schedule (SOMATROGON) vs. Once Daily GH Injection Schedule (SOMATROPIN) By Baseline Burden Subgroup in Paediatric Growth Horm ...

    Jan 1, 2022, 00:00

  • POSA92 Annual Health Insurance Treatment Cost of Non-Insulin-Dependent Diabetes with Other Specified Complications Based on Routinely Collected Financing Data

    Jan 1, 2022, 00:00

  • POSA251 Demand and Availability of Intravenous Injections for Patients with Retinal Diseases in the Russian Federation

    Jan 1, 2022, 00:00

  • POSB93 Conversion from Subcutaneous Trastuzumab to Trastuzumab-Dkst in Metastatic Breast Cancer: Comparative Cost-Efficiency Modelling between US and France

    Jan 1, 2022, 00:00

  • POSA126 An Economic Analysis of Empagliflozin Versus Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (HFREF) in the United Kingdom (UK)

    Jan 1, 2022, 00:00

  • POSA12 Analysis of the Evolution of Functional Biomechanical Parameters and Patient-Reported Outcome Measures in Total Knee Arthroplasty

    Jan 1, 2022, 00:00

  • POSB11 Correlation and Prognostic Value of Surrogate Endpoints and Overall Survival (OS) in Multiple Myeloma (MM): A Systematic Literature Review (SLR)

    Jan 1, 2022, 00:00

  • POSB39 Healthcare Resource Utilisation and Costs of Patients with Anaemia of CKD in Spain: Analysis from Two Retrospective Studies (TUNE AND RIKAS)

    Jan 1, 2022, 00:00

  • POSB426 Long-Term Time-Varying Survival Treatment Effect in the Presence of Scheduled Switch from Placebo to Active Treatment

    Jan 1, 2022, 00:00

  • POSA393 Online Risk Calculator Using Machine Learning for Prediction of Survival After Hospital Discharge from COVID-19 Infection

    Jan 1, 2022, 00:00

  • POSC277 Assessment Methods: of Artificial Intelligence Supported Health Technologies: A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSC186 Higher Rates of Complications and Health-Care Resource Utilisation in Achondroplasia Compared to the General Population: A Matched Cohort Study Using the Cprd-HES Database

    Jan 1, 2022, 00:00

  • POSA95 Exploring the Role of Response to Treatment in Oncology Technology Appraisals

    Jan 1, 2022, 00:00

  • POSA111 Weight-Related Quality of Life and Loss of Productivity in the Schizophrenic Patient

    Jan 1, 2022, 00:00

  • P71 The Development of a Flexible and Easy to Tailor Disease Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma by Combining Trial and Real-World Data

    Jan 1, 2022, 00:00

  • POSC341 Comparison of PROPr and EQ-5D-3L in Lower Back Pain Patients

    Jan 1, 2022, 00:00

  • POSB307 Impact of Antidiabetic Treatment on Renal Function in Diabetics with Chronic Renal Failure

    Jan 1, 2022, 00:00

  • P23 Change in Healthcare Utilisation and Inpatient Mortality in Patients Hospitalised with Heart Failure during the Coronavirus Pandemic in England: A Retrospective Cross-Sectional Study Utilising HES

    Jan 1, 2022, 00:00

  • POSB3 Multidimensional Treatment Effect Network Meta-Analysis to Estimate Survival of Therapies for Patients with First-Line (1L) Advanced or Metastatic Renal Cell Carcinoma (ARCC) in France

    Jan 1, 2022, 00:00

  • POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey

    Jan 1, 2022, 00:00

  • Issues with Health Technology Assessment of Specialised Technologies

    Jan 1, 2022, 00:00

  • POSC339 The Effects of Zumba Fitness on the Physical Abilities of Children

    Jan 1, 2022, 00:00

  • POSC130 Global Economic Burden of Congenital Cytomegalovirus: A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSB257 Total Joint Replacement Outcomes Under Computed Navigation in Comparison with Traditional Methods

    Jan 1, 2022, 00:00

  • Methodological Developments in Survival Analytic Methods: to Inform Cost-Effectiveness Models

    Jan 1, 2022, 00:00

  • POSA264 Reimbursable Healthcare Apps (DIGA) in Germany: Which Factors Impact the BfArM’s2 Assessment Outcome and a Directory Listing?

    Jan 1, 2022, 00:00

  • POSB296 Cost Efficiencies for Spinal Cord Stimulation in Denmark: Impact of Battery Longevity for Non-Rechargeable Devices and a 1-Stage Approach

    Jan 1, 2022, 00:00

  • POSC276 Pharmacoeconomic Evaluation Criteria for Highly Specialised Technologies, and Subsequent Recommendations: A Comparison of NICE UK and the NCPE Ireland

    Jan 1, 2022, 00:00

  • POSC340 Health-Related Quality of Life Among Refractory/Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated with KTE-X19: Phase 2 Results from Zuma-3 Trial

    Jan 1, 2022, 00:00

  • POSC367 Differences between Patients and Experts in Health Attribute Values: The Value Adjusted Life Years Approach

    Jan 1, 2022, 00:00

  • POSC155 Work Productivity in Adult Patients with Atopic Dermatitis

    Jan 1, 2022, 00:00

  • POSB364 Systematic Literature Reviews (SLRS) of Economic Evaluations and Health Utility Studies of AML Treatments for Adults Receiving High Intensity Induction Therapy, with or without Maintenance Therapy

    Jan 1, 2022, 00:00

  • Epidemiology Public Health

    Jan 1, 2022, 00:00

  • P7 Evaluating Impact of Universal Varicella Vaccination Strategies on Clinical Burden of Varicella and Herpes Zosterin England and Wales

    Jan 1, 2022, 00:00

  • POSB62 Budget Impact Analysis of Ertugliflozin Inclusion in the List of Vital and Essential Medicines in Russian Federation

    Jan 1, 2022, 00:00

  • P4 Switching, Persistence and Adherence to Statin Therapy: A Retrospective Cohort Study Using the Australian National Pharmacy Data

    Jan 1, 2022, 00:00

  • POSA6 Use of Real-World Evidence to Evaluate Infliximab Biosimilars: A Scoping Review

    Jan 1, 2022, 00:00

  • POSC336 Investigation of the Requisition Indicators of "Kinesitherapie Respiratoire" in the Upper Rhine Region

    Jan 1, 2022, 00:00

  • P22 COVID-19 Pandemic Impacts Volume of Evaluation M) Telehealth Visits within Community Oncology Practices

    Jan 1, 2022, 00:00

  • POSA362 Symptom Assessment in Adolescents and Adults with Celiac Disease

    Jan 1, 2022, 00:00

  • POSA207 Expert Consensus on Payment Models for Multi-Indication Therapies

    Jan 1, 2022, 00:00

  • POSB368 Understanding the Impact of Atopic Dermatitis in Portuguese Patients: Results from an Analytical Observational Study

    Jan 1, 2022, 00:00

  • POSA337 Comparison of Trunk Muscle Enhancement Effects of TRX Suspension Trainer and Physioball Devices

    Jan 1, 2022, 00:00

  • POSC65 Cost-Benefit Analysis of Ready-to-Administer Noradrenaline for Hypotensive Emergency on Intensive Care

    Jan 1, 2022, 00:00

  • POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study

    Jan 1, 2022, 00:00

  • POSB372 Patients' Preferences for Connected Insulin Pens: A Discrete Choice Experiment Among Diabetes Patients in the UK and US

    Jan 1, 2022, 00:00

  • Disclaimer

    Jan 1, 2022, 00:00

  • POSB190 Analysis of the Prevalence of Disease Areas in the Gene Therapy Pipeline: From Ultra-Rare to Prevalent

    Jan 1, 2022, 00:00

  • POSB430 Elicitation of Health State Utilities Associated with Varying Severities of Dry Eye Disease

    Jan 1, 2022, 00:00

  • POSC269 Health Technology Assessment Implementation for Development of Basic Benefit Package in 2021 in Ukraine

    Jan 1, 2022, 00:00

  • POSC309 A Pragmatic Patient-Finding Methodology in the Ultra-Rare Disease Fibrodysplasia Ossificans Progressiva (FOP)

    Jan 1, 2022, 00:00

  • POSC83 Estimating the Clinical and Economic Benefits of Optimising Management of Patients with Hemophilia A in Developing Countries

    Jan 1, 2022, 00:00

  • POSC405 Absence Time and Payments Due to Sick Leave, Long- and Short-Term Disability and Workers' Compensation for Employees with Musculoskeletal Conditions in the United States

    Jan 1, 2022, 00:00

  • POSA104 The Cost of Metastatic Colorectal Cancer Patients with BRAFV600E Mutations in Greece

    Jan 1, 2022, 00:00

  • POSA161 Economic Analysis of NHS England's Policy to Reduce the Carbon Impact of Inhalers by Encouraging a Rapid Prescribing Switch from Pressurised Metered Dose Inhalers (PMDIS) to Dry Powder Inhalers (DPIS)

    Jan 1, 2022, 00:00

  • POSB139 Predicting Quality of Life through Changes in Menstrual Blood Loss in Patients with Uterine Fibroids

    Jan 1, 2022, 00:00

  • POSA53 The Cost-Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease and Heart Failure in the UK

    Jan 1, 2022, 00:00

  • POSB220 Bridging the Evidence Gap for Tumor-Agnostic Therapies

    Jan 1, 2022, 00:00

  • POSB200 Type of Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-Control Study

    Jan 1, 2022, 00:00

  • POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2

    Jan 1, 2022, 00:00

  • POSB23 Tafasitamab Plus Lenalidomide (T-L) Versus Standard of Care (SoC) Including 3 Rituximab-Based Treatments or Lenalidomide Monotherapy in Patients with Non-Transplant Eligible Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NTE R ...

    Jan 1, 2022, 00:00

  • POSC384 Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in UK: Burden of Disease

    Jan 1, 2022, 00:00

  • POSB250 The Influence of Iron-Deficiency Anemia (IDA) Therapy on Clinical Outcomes and Healthcare Resource Consuptions in Chronic Kidney Disease Patients Affected By IDA: A Retrospective Study Among Italian Population

    Jan 1, 2022, 00:00

  • POSA18 Assessment of Causality and Drug Causing Cutaneous Adverse Drug Reaction in Tertiary Care Hospital, Bangalore: An Observational Study

    Jan 1, 2022, 00:00

  • POSA109 The Impact of Improving the Current Approach to Chronic Obstructive Pulmonary Disease Within the Spanish National Health System: A Social Return on Investment Analysis

    Jan 1, 2022, 00:00

  • POSC121 Budget Impact Analysis of an Alternative Meningococcal Conjugate Vaccine for High-Risk Infants in Egypt

    Jan 1, 2022, 00:00

  • POSA223 Dynamics of EU Market Exclusivity: The Impact of Orphan Designation on Generic or Biosimilar Entry

    Jan 1, 2022, 00:00

  • P36 Unmet Needs of Caregivers in Locally Advanced or Metastatic Bladder Cancer from Social Media in the US

    Jan 1, 2022, 00:00

  • POSA292 MSCopilot® as a Digital Tool to Collect Patients’ Insights in Health Economics Research in Multiple Sclerosis

    Jan 1, 2022, 00:00

  • Acknowledging Patient Heterogeneity in Economic Evaluations in Schizophrenia: A Systematic Review [Editor's Choice]

    Jan 1, 2022, 00:00

  • POSC420 Assessing Algorithms to Identify Asthma Patients Using Multiple Inhaler Triple Therapy (comprising ICS, LABA, LAMA) in a Real-World Database

    Jan 1, 2022, 00:00

  • POSA420 Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database

    Jan 1, 2022, 00:00

  • POSB374 Patient and Caregiver Preferences for Treatment Attributes in Type 2 and Non-Ambulatory Type 3 Spinal Muscular Atrophy: A Pan-European Stated Preference Survey

    Jan 1, 2022, 00:00

  • POSB60 Evolution of Direct Medical Costs Associated with Respiratory Syncytial Virus Disease in Older Adults: A Retrospective Database Analysis from 2008 to 2017

    Jan 1, 2022, 00:00

  • POSB254 Mechanical Thrombectomy for Acute Ischemic Stroke: Systematic Review and Meta-Analysis

    Jan 1, 2022, 00:00

  • POSB167 Cost-Effectiveness of Tobacco Control Strategies in Indonesia

    Jan 1, 2022, 00:00

  • POSA74 Accounting for Population Heterogeneity Over-Time in Estimating Costs and Outcomes in Cohort-Based Health-Economic Evaluations

    Jan 1, 2022, 00:00

  • POSB366 An Interventional Study on Reduction of Medication Errors and Comparison of Different Medication Errors and Comparison of Different Medication Errors in Paediatrics

    Jan 1, 2022, 00:00

  • POSA402 Impact of Comorbid Cannabis Use Disorders in Schizophrenia: An Electronic Health Record Real World Data Study

    Jan 1, 2022, 00:00

  • POSA314 Predicting Outcomes in Multiple Sclerosis Through Machine Learning Using Data from Pharmaceutical Consultation

    Jan 1, 2022, 00:00

  • POSC297 Assessing and Comparing the Situation of Respiratory Endoscopy in Catalonia in 2019 with Previous Audits and Defining Quality Kpis

    Jan 1, 2022, 00:00

  • POSB75 What Is the Net Added Value of Personalised Medicine? A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSB361 Quality of Life in Advanced Melanoma Patients in the Era of Novel Immuno- and Targeted Therapies

    Jan 1, 2022, 00:00

  • POSA15 Evaluation of Efficacy and Safety of Nivolumab and Pembrolizumab in Elderly Cancer Patients

    Jan 1, 2022, 00:00

  • POSB186 Global Clinical, Economic, and Humanistic Burden of Marginal Zone Lymphoma: A Systematic Literature Review

    Jan 1, 2022, 00:00

  • POSA387 Healthcare Resource Utilization and Direct Medical Costs in French Patients Receiving Treatment for Hypogammaglobulinemia: A National Cohort Study

    Jan 1, 2022, 00:00

  • Author Reply

    Jan 1, 2022, 00:00

  • POSA269 Above and Beyond: Assessing the Nature and Impact of Additional Considerations Above Clinical and Cost Effectiveness by 8 HTA Agencies for a Rare Disease Area

    Jan 1, 2022, 00:00

  • POSB37 Real-World Costs of Reintervention in Stenting with Femoropopliteal Artery Revascularization

    Jan 1, 2022, 00:00

  • POSB133 Translating Findings from Affirm-AHF: Events Avoided and Cost Savings Associated with the Use of Ferric Carboxymaltose for the Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction in Italy ...

    Jan 1, 2022, 00:00

  • POSB137 Trends in Absence Time and Payments Due to Sick Leave, Long- and Short-Term Disability and Workers' Compensation for Employees with Respiratory Conditions

    Jan 1, 2022, 00:00

  • POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States

    Jan 1, 2022, 00:00

  • POSA226 Analysis of Requirement of Implantation for Implantable Cardioverter Defibrillator in the Russian Federation

    Jan 1, 2022, 00:00

  • POSB185 Epidemiology and Management of Parathyroid Gland Disorders in Spain over 15 Years: A Retrospective Multicenter Analysis

    Jan 1, 2022, 00:00

  • POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada

    Jan 1, 2022, 00:00

  • POSB76 Budget Impact Analysis of Ponesimod for Relapsing Multiple Sclerosis in the United States

    Jan 1, 2022, 00:00

  • POSC59 Healthcare Expenditures of Older United States Adults with Self-Reported Pain and Functional Limitations: A Cross-Sectional, Retrospective Database Study

    Jan 1, 2022, 00:00

  • POSB293 The Experience of an Outsourced Comprehensive Genomic Profiling Service in Italy

    Jan 1, 2022, 00:00

  • POSA358 The Impact of Patient-Reported Outcomes in Market Access: A Literature Review, Regulatory Evidence Assessment Framework and Study

    Jan 1, 2022, 00:00

  • POSB313 Predicting Chronic Kidney Disease in Type 2 Diabetes Using Patient-level Simulation: Outcomes, Markers, Risk Factors, and Sequelae Identified in a Systematic Review

    Jan 1, 2022, 00:00

  • POSB243 Oncologists’ Preferences for First-Line (1L) Treatment of Locally Advanced/Unresectable or Metastatic Urothelial Carcinoma (aUC)

    Jan 1, 2022, 00:00

  • POSC319 Analysis of Treatment Sequences across Seven Immunological Diseases and the Variability in Efficacy for Patients By Disease: Opportunities for Improvement

    Jan 1, 2022, 00:00

  • CHEERS to Updated Guidelines for Reporting Health Economic Evaluations!

    Jan 1, 2022, 00:00

  • POSC356 Pilot Study for Assessment of Health State Utilities Associated with False-Positive Cancer Screening Results

    Jan 1, 2022, 00:00

  • POSA273 Systematic Review, Meta-Analysis of Per OS Administered Drugs in Cystic Fibrosis

    Jan 1, 2022, 00:00

  • A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older Patients

    Jan 1, 2022, 00:00

  • POSC185 Healthcare Utilisation, Health Inequality and the Impact of COVID-19 on Idiopathic Pulmonary Fibrosis (IPF) Care in England: A Retrospective Cohort Study

    Jan 1, 2022, 00:00

  • POSC429 Clinical Trial Site Attitudes and Experiences in Managing BYOD ePRO: Results of a Qualitative Study

    Jan 1, 2022, 00:00

  • POSC393 The Clinical and Economic Burden Imposed By Ileostomy Creation: A Danish Registry Study

    Jan 1, 2022, 00:00

  • POSA129 Health Economic Impact of Phenylketonuria: A Retrospective Claims Database Study in France

    Jan 1, 2022, 00:00

  • POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case

    Jan 1, 2022, 00:00

  • POSA291 Impact of Intrepid® Hybrid Tip on Incidence and Cost of Posterior Capsule Ruptures in Cataract Surgery

    Jan 1, 2022, 00:00

  • POSA219 What Is the Value of Deep-Brain Stimulation in Parkinson's Disease?

    Jan 1, 2022, 00:00

  • P18 Patient Preferences for Attributes of a Multi-Cancer Early Detection Test: A Discrete Choice Experiment (DCE) Quantitative Pilot Study

    Jan 1, 2022, 00:00

  • POSA237 Intra Family Encouragement in Self-Management of Type 2 Diabetes: A Cross Sectional Evaluation in the Indian Population

    Jan 1, 2022, 00:00

  • POSB241 A Retrospective Study of the Management of Anaemia in Patients with Dialysis-Dependent Chronic Kidney Disease in Fran The Amack Study

    Jan 1, 2022, 00:00

  • POSC189 A Patient Registry-Based Cross-Sectional Study of the Burden and Management of Comorbid Psoriatic Arthritis (PsA) in Patients with Systemic Lupus Erythematosus (SLE)

    Jan 1, 2022, 00:00

  • POSA9 Comparison of Risk Factors and Health Outcomes of Recanalised and Non-recanalised Patients with Acute Ischaemic Stroke: A Descriptive Analysis

    Jan 1, 2022, 00:00

  • POSA87 Annual Health Insurance Treatment Cost of Mental and Behavioural Disorders Due to Use of Opioids Based on Routinely Collected Financing Data

    Jan 1, 2022, 00:00

  • POSC127 Evolution of Direct Medical Costs Associated with Respiratory Syncytial Virus Disease in Children Younger Than 5 Years: A Retrospective Database Analysis from 2008 to 2017

    Jan 1, 2022, 00:00

  • POSC20 Treatment Patterns and Survival Among Patients With Advanced Renal Cell Cancer: Results of a Nationwide Cohort Study in Denmark

    Jan 1, 2022, 00:00

  • The ICEpop Capability Measure for Adults Instrument for Capabilities: Development of a Tariff for the Dutch General Population

    Jan 1, 2022, 00:00

  • POSC388 Treatment Patterns and Healthcare-Resource Utilization Among Patients with Advanced Esophageal Squamous Cell Carcinoma Who Received Platinum and Fluoropyrimidine Treatment at First Line

    Jan 1, 2022, 00:00

  • POSB116 Budget Impact Analysis of Pegaspargase in Acute Lymphoblastic Leukemia in Spain

    Jan 1, 2022, 00:00

  • POSB8 Efficacy and Safety Results from Randomized Controlled Trials (RCTS) Evaluating Adjuvant Treatment after Radical Resection (RR) of Muscle Invasive Urothelial Carcinoma (MIUC): A Systematic Literature Review (SLR)

    Jan 1, 2022, 00:00

  • POSA419 Diabetes Treatment Cost in Lebanon Using a Real-World Dataset from Private Payer

    Jan 1, 2022, 00:00
  • «
  • 31
  • 32 (current)
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »